YUMANITY THERAPEUTICS, INC.

(YMTX)
  Report
Delayed Nasdaq  -  03:59 2022-08-11 pm EDT
1.660 USD   -1.19%
08/04YUMANITY THERAPEUTICS : Reports Second Quarter 2022 Financial Results and Recent Corporate Developments - Form 8-K
PU
08/04YUMANITY THERAPEUTICS : Quarterly Report for Quarter Ending June 30, 2022 (Form 10-Q)
PU
08/04YUMANITY THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Sector Update: Health Care Stocks Edging Higher This Afternoon

06/06/2022 | 01:35pm EDT


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
JOHNSON & JOHNSON -2.07% 167.14 Delayed Quote.-2.30%
LIVERAMP HOLDINGS, INC. -1.26% 22.69 Delayed Quote.-52.68%
NASDAQ COMPOSITE -0.58% 12779.91 Real-time Quote.-17.83%
PRAXIS PRECISION MEDICINES, INC. -11.11% 4.24 Delayed Quote.-78.48%
SHOCKWAVE MEDICAL, INC. 1.48% 281.52 Delayed Quote.57.86%
SOTERA HEALTH COMPANY 2.41% 19.99 Delayed Quote.-15.12%
URBAN OUTFITTERS, INC. 4.67% 21.95 Delayed Quote.-25.24%
YUMANITY THERAPEUTICS, INC. -1.19% 1.66 Delayed Quote.-43.92%
All news about YUMANITY THERAPEUTICS, INC.
08/04YUMANITY THERAPEUTICS : Reports Second Quarter 2022 Financial Results and Recent Corporate..
PU
08/04YUMANITY THERAPEUTICS : Quarterly Report for Quarter Ending June 30, 2022 (Form 10-Q)
PU
08/04YUMANITY THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Conditio..
AQ
08/04Yumanity Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Mon..
CI
08/04YUMANITY : Q2 Earnings Snapshot
AQ
08/04Earnings Flash (YMTX) YUMANITY THERAPEUTICS Reports Q2 Revenue $1.66M
MT
08/04Yumanity Therapeutics Reports Second Quarter 2022 Financial Results and Recent Corporat..
AQ
07/20YUMANITY THERAPEUTICS, INC. : Regulation FD Disclosure, Financial Statements and Exhibits ..
AQ
07/05YUMANITY THERAPEUTICS INVESTOR ALERT : Kahn Swick & Foti, LLC Investigates Yumanity Therap..
BU
06/28YUMANITY THERAPEUTICS : Kineta Announces Appointment of Thierry Guillaudeux, PhD to Chief ..
PU
More news
Analyst Recommendations on YUMANITY THERAPEUTICS, INC.
More recommendations
Financials (USD)
Sales 2021 8,04 M - -
Net income 2021 -39,5 M - -
Net cash 2021 8,81 M - -
P/E ratio 2021 -0,77x
Yield 2021 -
Capitalization 18,0 M 18,0 M -
EV / Sales 2020 17,6x
EV / Sales 2021 2,74x
Nbr of Employees 41
Free-Float 86,6%
Chart YUMANITY THERAPEUTICS, INC.
Duration : Period :
Yumanity Therapeutics, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends YUMANITY THERAPEUTICS, INC.
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Last Close Price 1,66
Average target price
Spread / Average Target -
EPS Revisions
Managers and Directors
Richard Peters President, Chief Executive Officer & Director
Michael D. Wyzga Chief Financial Officer, Treasurer & Senior VP
N. Anthony Coles Non-Executive Chairman
Brigitte Robertson Chief Medical Officer
Daniel Tardiff Research Head
Sector and Competitors
1st jan.Capi. (M$)
YUMANITY THERAPEUTICS, INC.-43.92%18
GILEAD SCIENCES, INC.-13.99%78 273
VERTEX PHARMACEUTICALS33.04%74 927
REGENERON PHARMACEUTICALS, INC.-1.21%66 700
WUXI APPTEC CO., LTD.-20.30%40 674
BIONTECH SE-38.48%38 540